Top Companies - Adult Vaccine Industry

The growing number of government initiatives to prevent specific diseases and epidemics, as well as various countries conducting national immunisation programmes to provide vaccination and raise awareness about the benefits of vaccination in combating fatal diseases, are expected to drive the global adult vaccines market.

One of the primary issues impeding the growth of the worldwide adult vaccines market is a big population that has not been immunised against specific illnesses such as Tetanus, Diphtheria, and Pertussis.

According to Coherent Market Insights, the global Adult Vaccine Market is estimated to be valued at US$ 16,790.11 million in 2022 and is expected to exhibit a CAGR of 7.1% during the forecast period (2022-2030).

Leading Companies in the Adult Vaccine Industry

1. Merk & Co.

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.  Merck known as MSD outside the United States and Canada, on June 29’ 2022 announced the launch of the Merck Digital Sciences Studio (MDSS) to enable the generation of innovative technologies for drug discovery and development.

2. Pfizer Inc.

The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19. Pfizer inc. was founded in 1849 and is headquartered in New York, New York. Pfizer in collaboration with BioNTech on November 2022 Announced their Updated Clinical Data for Omicron BA.4/BA.5-Adapted Bivalent Booster Demonstrating Substantially Higher Immune Response in Adults Compared to the Original COVID-19 Vaccine.

3. Sanofi Pasteur

On November 2022, Sanofi along and GSK’s next generation COVID-19 booster vaccine VIdPrevtyn Beta have been approved by the European Commission and will be readily available for fall-winter COVID-19 vaccination campaigns in Europe. Sanofi operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare in in the United States, Europe, and internationally. Sanofi was founded in 1973 and is headquartered in Paris, France.

4. Serum Institute of India Pvt. Ltd.

On Spetmeber 2022, India’s first indigenously developed Quadrivalent Human Papillomavirus vaccine (qHPV) ‘CERVAVAC’ was announced, it was an outcome of a partnership between Serum Institute of India (SII), Department of Biotechnology (DBT) and the Biotechnology Industry Research Assistance Council (BIRAC). Serum Institute of India Pvt. Ltd. is now the world's largest vaccine manufacturer by number of doses produced and sold globally (more than 1.5 billion doses) which includes Polio vaccine, Diphtheria, Tetanus, Pertussis, Hib, BCG, r-Hepatitis B, Measles, Mumps, Rubella as well as Pneumococcal and Covid-19 vaccines. Serum Institute of India was founded in 1966, headquartered in Pune, Maharashtra, India is is ranked as India's No. 1 biotechnology company.  Serum Institute of India provided COVID vaccines, ChAdOx1 nCoV-1 Coronus virus Vaccine (Recombinant)- COVISHIELD.

5. Johnson & Johnson Services

The company was founded in 1886 and is based in New Brunswick, New Jersey. On February 27, 2021, single-dose COVID-19 vaccine, developed by the Janssen Pharmaceutical Companies of Johnson & Johnson, have been approved by the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA), to prevent COVID-19 in individuals 18 years of age and older.

6. GlaxoSmithKline Plc

GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom. GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. On May 2022, GSK to acquire clinical-stage biopharmaceutical company Affinivax, Inc. Affinivax is pioneering the development of a novel class of vaccines. On August 2022, GSK and IQVIA launch Vaccine Track, a data trend platform to help improve adult vaccination in communities nationwide.

7. CSL Limited

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus.  CSL Limited was founded in 1916 and is headquartered in Parkville, Australia. On November 2022, revealed Collaboration and license agreement with Arcturus Therapeutics aims to accelerate next-generation mRNA capabilities in influenza, pandemic preparedness and other selected respiratory viral pathogens -- including a near term COVID-19 vaccine.

8. AstraZeneca Plc.

AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom. On August 2021, Positive high-level results from the PROVENT Phase III pre-exposure prophylaxis trial showed AstraZeneca's AZD7442 achieved a statistically significant reduction in the incidence of symptomatic COVID-19, the trial's primary endpoint.

9. Medimmune

MedImmune is the global biologics research and development arm of AstraZeneca, a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialisation of small molecule and biologic prescription medicines. The MedImmune headquarters is located in Gaithersburg, Md., one of AstraZeneca’s three global R&D centres.  The company was founded in 1988.

*Definition-

Vaccination and immunization help to avoid infections in both adults and children. Vaccines are biological solutions containing an agent that is similar to the disease-causing germs. They are frequently prepared from inactivated bacteria, toxins, or surface proteins.